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MaBACKGROUND Recently published appropriate use criteria (AUC) for initial pediatric outpatient transthoracic
echocardiography (TTE) have not yet been evaluated for clinical applicability.
OBJECTIVES This study sought to determine the appropriateness of TTE as currently performed in pediatric cardiology
clinics, diagnostic yield of TTE for various AUC indications, and any gaps in the AUC document.
METHODS Data were prospectively collected from patients undergoing initial outpatient TTE in 6 centers. TTE
indications (appropriate [A], may be appropriate [M], or rarely appropriate [R]) and ﬁndings (normal, incidental,
or abnormal) were recorded.
RESULTS Of the 2,655 studies ordered by 102 physicians, indications rated A, M, and R were found in 1,876 (71%),
316 (12%), and 319 studies (12%), respectively, and 144 studies (5%) were unclassiﬁable. Twenty-four of 113 indications
(21%) were not used. Innocent murmur and syncope or palpitations with no other indications of cardiovascular disease, a
benign family history, and normal electrocardiogram accounted for 75% of indications rated R. Pathologic murmur had
the highest yield of abnormal ﬁndings (40%). Odds of an abnormal ﬁnding in an A or M TTE were 6 times that of R
(95% conﬁdence interval [CI]: [2.8 to 12.8]). Abnormal ﬁndings were more common in patients <1 year of age
than in those >10 years of age (odds ratio: 6.4; 95% CI: 4.7 to 8.7). Age was a signiﬁcant predictor of an abnormal ﬁnding
after adjusting for indication and site (p < 0.001).
CONCLUSIONS Most TTEs ordered in pediatric cardiology clinics were for indications rated A. AUC ratings successfully
stratiﬁed indications based on the yield of abnormal ﬁndings. This study identiﬁed differences in the yield of TTE based
on patient age and most common indications rated R. These ﬁndings should inform quality improvement efforts and
future revisions of the AUC document. (J Am Coll Cardiol 2015;66:1132–40) © 2015 by the American College of
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AB BR E V I A T I O N S
AND ACRONYM S
A = appropriate
ASD = atrial septal defect
AUC = appropriate use criteria
ECG = electrocardiogram
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1133in adult cardiology, this process was extended to pe-
diatrics, and the ﬁrst pediatric AUC in any area was
recently published for TTE (3). This document fo-
cuses on the initial outpatient evaluation of pediatric
patients, using TTE, which is an area of high use. The
document was developed using a well-deﬁned meth-
odology that has been reﬁned over the years (4).SEE PAGE 1141
M = may be appropriate
OR = odds ratio
PDA = patent ductus arteriosus
R = rarely appropriate
TTE = transthoracic
echocardiography
VSD = ventricular septal defectImplementation studies evaluating the use of AUC
in adult cardiology have been instrumental in recog-
nizing the appropriateness of the imaging studies and
identifying any deﬁciencies in the document (5–7).
Furthermore, these studies have been helpful in
engaging physicians in quality improvement projects
related to test-ordering behavior and in lowering the
number of tests for indications rated as rarely
appropriate (8,9). The purpose of this study was to
determine the clinical applicability of the AUC docu-
ment in pediatric cardiology clinics in terms of care
provided prior to the release of this document, to
evaluate the diagnostic yield of the various AUC in-
dications, and to identify any missing and unused
indications in this document.
METHODS
STUDY DESIGN. Six centers participated in this pro-
spective cross-sectional quality improvement pro-
ject, including Emory University School of Medicine
and Children’s Healthcare of Atlanta, Children’s
Hospital at Monteﬁore, Mayo Clinic Rochester, Mas-
sachusetts General Hospital, Miami Children’s Hos-
pital, and Morgan Stanley Children’s Hospital of
NewYork-Presbyterian. The proposal for this project
was presented to the respective Institutional Review
Boards of the participating sites and did not qualify
as a research project for all centers except for
Morgan Stanley Children’s Hospital of NewYork
Presbyterian, where the study was reviewed and
approved by their Institutional Review Board. Data
were collected from April to September 2014,
before the online release of the AUC document. All
clinicians participating in the study were made
aware of the data collection but were unaware of
the contents of the AUC document. All patients
#18 years of age undergoing initial TTE evaluation
in a pediatric cardiology clinic were included. Pa-
tients previously evaluated by TTE during hospitali-
zation or as outpatients, and those who were referred
to a cardiology clinic only for a TTE without any
clinical evaluation by the pediatric cardiologist,
and those seen by investigators of this study were
excluded.DATA COLLECTION AND RATING OF
INDICATIONS. Patient and visit data,
including patient demographics, date of
study, name of the ordering physician, and
reason for TTE, were entered on a data
collection sheet by the clinician prior to
ordering the TTE. The reasons for TTE were
divided into 10 broad categories: murmur,
chest pain, syncope, palpitations, abnormal
electrocardiogram (ECG) results, abnormal
test results other than ECG, systemic disorder,
family history of cardiovascular disease, con-
ditions that increase cardiovascular risk, and
other reasons that did not ﬁt into any of the
above-listed categories. For patients with
more than 1 indication for TTE, 1 was designated as the
primary indication by the clinician, and the others
were considered secondary indications. Site in-
vestigators reviewed the data collection sheet and
medical records from the clinic visit to assign the AUC
indication for the TTE by using the tables and ﬂow di-
agrams in the AUC document (3). Indicationswere then
rated as appropriate (A), may be appropriate (M), or
rarely appropriate (R) based on the AUC document (4).
If the clinical scenario did not ﬁt into any of the 113
indications listed in the document, it was considered
unclassiﬁable. If there was a question about assign-
ment of indication to a case scenario, it was referred for
adjudication (R.S. and W.W.L.).
All de-identiﬁed data were entered into the
Research Electronic Data Capture (REDCap) system,
which was maintained by the core site at Emory Uni-
versity School of Medicine and Children’s Healthcare
of Atlanta. Individual sites maintained their own
enrollment logs with their corresponding REDCap-
assigned identiﬁcation numbers.
CLASSIFICATION OF TTE FINDINGS. Site investigators
reviewed TTE ﬁndings and graded the severity of
abnormal ﬁndings. TTE ﬁndings were classiﬁed as
normal, incidental, or abnormal. Incidental ﬁndings
included patent foramen ovale, small patent ductus
arteriosus (PDA) in a neonate, peripheral pulmonary
artery stenosis, left superior vena cava, tiny coronary
artery ﬁstula, retroaortic innominate vein, common
origin of innominate artery and left common carotid
artery, and left aortic arch with an aberrant right
subclavian artery. Abnormal ﬁndings were divided
into those that were related to the indication and
those that were not. Each of these ﬁndings were
further classiﬁed based on their clinical relevance as
minor, moderate, or severe. Minor ﬁndings were
other than those listed under incidental ﬁndings that
might require follow-up but no intervention would
be anticipated. Minor ﬁndings included small atrial
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1134septal defect (ASD), small ventricular septal defect
(VSD), small PDA beyond the neonatal period, mild
pulmonary stenosis, mitral valve prolapse, or
bicuspid aortic valve without stenosis or insufﬁ-
ciency. Moderate ﬁndings were those that altered
patient management but did not require urgent
intervention (e.g., moderate-to-large secundum ASD,
ASD other than secundum type, moderate-to-large
VSD, moderate-to-large PDA, bicuspid aortic valve
with stenosis or insufﬁciency, and anomalous aortic
origin of a coronary artery). Severe ﬁndings were
those that required urgent hospitalization or inter-
vention (e.g., critical valvular stenosis, moderate or
severe coarctation of aorta, severely reduced cardiac
function, large pericardial effusion, or anomalous
origin of coronary artery from pulmonary artery).
STUDY OUTCOMES. The primary outcome measure
was the number of studies ordered for indications
rated R. Secondary outcome measures were the yield
of abnormal ﬁndings for various AUC indications,
inﬂuence of age on the diagnostic yield of TTE, in-
dications for studies that were unclassiﬁable, and
unused AUC indications.
STATISTICAL ANALYSIS. Statistical analyses were
performed using SAS version 9.4 software (Cary,
North Carolina). Statistical signiﬁcance was assessed
at the 0.05 level. Descriptive statistics were calcu-
lated for all variables of interest and included me-
dians and 25th to 75th interquartile (IQR) ranges and
counts and percentages, when appropriate. Normality
of continuous variables was assessed using histo-
grams, normal probability plots, and the Anderson-
Darling test for normality. Odds ratios (ORs) and
95% conﬁdence intervals (CIs) were used to compare
risks of abnormal ﬁndings in different patient sub-
groups by using logistic regression models. When we
examined the odds of an abnormal ﬁnding among
patients with both primary and secondary TTE in-
dications versus those with only a primary indica-
tion, patients with only a primary indication were
treated as the reference group. In addition, when we
assessed the impact of TTE rating on odds of an
abnormal ﬁnding, indications rated R were treated as
the reference group and were compared to those with
indications rated A or M. In a multivariable logistic
regression model, we examined the impact of pri-
mary indication and age on the outcome abnormal
ﬁnding, while controlling for clustering of patients
within sites.
RESULTS
During the study period, there were 2,655 in-
itial outpatient TTE evaluations ordered by 102physicians. The median age of the patients was 10
years (IQR: 3 to 15 years of age). The median number
of TTE studies ordered per physician was 16 (IQR: 5 to
37 studies).
INDICATIONS AND RATINGS OF TTEs. Of 2,655
studies, the indications for ordering TTE were rated A
in 1,876 studies (71%), M in 316 studies (12%), and R in
319 studies (12%). One hundred forty-four studies
(5%) had a reason for TTE that was not listed in the
AUC document and were therefore unclassiﬁable
(Central Illustration). The 3 most common indications
for TTEs rated A were pathologic murmur (n ¼ 446),
exertional chest pain (n ¼ 355), and abnormal ECG
without symptoms (n ¼ 279). For those rated M, the
3 most common indications were positive family
history of congenital left-sided heart lesion (n ¼ 71);
chest pain with other symptoms or signs of cardio-
vascular disease, a benign family history and a normal
ECG (n ¼ 41); and unexplained pre-syncope (n ¼ 38).
For those rated R, the 3 most common indications
were presumptively innocent murmur (n ¼ 172),
syncope with no other symptoms or signs of cardio-
vascular disease, a benign family history and a
normal ECG (n ¼ 26); and palpitations with no other
symptoms of signs of cardiovascular disease, a benign
family history, and a normal ECG (n¼ 23).
The 5 most commonly used AUC indications,
in order of frequency, were pathologic murmur
(n ¼ 446), exertional chest pain (n ¼ 355), abnormal
ECG without symptoms (n ¼ 279), presumptively
innocent murmur (n ¼ 172), and presumptively inno-
cent murmur with signs, symptoms, or ﬁndings of
cardiovascular disease (n ¼ 160). These 5 indications
accounted for 53% of studies. One or more secondary
indications were present in 533 patients (20%).
DIAGNOSTIC YIELD OF TTE. Overall, 2,251 TTEs
results (85%) were normal, 130 (5%) had only an
incidental ﬁnding other than an isolated patent
foramen ovale, and 274 (10%) had an abnormal
ﬁnding with or without an incidental ﬁnding. The
percentages of abnormal ﬁndings in each appropri-
ateness category and unclassiﬁable indications are
shown in the Central Illustration. The OR for an
abnormal ﬁnding on TTE rated as A or M versus R
was 6.0 (95% CI: 2.8 to 12.8). Table 1 shows the diag-
nostic yield of the 3 most frequently used AUC in-
dications for each of the 9 tables provided in the AUC
document (3). The frequency of abnormal ﬁndings
varied signiﬁcantly depending on the indication.
Among the top 3 TTE indications rated A, pathologic
murmur (AUC indication 41) had the highest yield
of abnormal ﬁndings (178 of 446 [40%]), whereas
exertional chest pain (AUC indication 30) had the
CENTRAL ILLUSTRATION Pediatric Echocardiography AUC Implementation Study: TTE Appropriateness Rating and TTE Findings
for Each Appropriateness Rating and Unclassiﬁable Studies
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(Left) Appropriateness rating of 2,655 transthoracic echocardiogram (TTE) studies ordered by pediatric cardiologists. (Right) Percentages of normal, incidental,
and abnormal ﬁndings by TTE for indications rated appropriate (n ¼ 1,876), may be appropriate (n ¼ 316), or rarely appropriate (n ¼ 319) and unclassiﬁable indications
(n ¼ 144). AUC ¼ appropriate use criteria.
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1135lowest yield (2 of 355 [0.6%]). Abnormal ﬁndings were
noted in 10.7% (227 of 2123) of studies with only
a primary indication and 9% (47 of 532) of studies
with a primary and a secondary indication (OR: 0.8;
95% CI: 0.6 to 1.2).
The 3 most common abnormal ﬁndings for each
appropriateness category, severity of abnormal ﬁnd-
ings and the proportion of those related to the indi-
cation are shown in Table 2. The majority of abnormal
ﬁndings (226 of 245 [92%]) for TTEs done for in-
dications rated A were related to the indication,
whereas for indications rated R, only 1 of 7 (14%) was
related. That patient had a TTE performed for obesity,
without having other cardiovascular risk factors
(AUC indication 76) and was noted to have mild left
ventricular hypertrophy on TTE. All 5 TTEs with se-
vere abnormalities were done for indications rated A.
The ﬁndings on these TTEs included double-outlet
right ventricle with coarctation of aorta, dilated car-
diomyopathy, severe pulmonary valve stenosis,
moderate pulmonary hypertension with pericardial
effusion, and coarctation of aorta. The 3 TTEs with
moderate abnormalities for indications rated R hadincidental discovery of a coronary anomaly that was
unrelated to the indication for the study. All of the
abnormal ﬁndings in TTEs done for unclassiﬁable
reasons were noted to be minor, and 3 of the 8 were
related to the reason for the study (ﬁnding of a
bicuspid aortic valve in 2 patients and mitral valve
prolapse in 1 patient, when the reason for the study
was a click). Of the 130 studies that had only inci-
dental ﬁndings, peripheral pulmonary artery stenosis
(n ¼ 87) and patent foramen ovale (n ¼ 60) were the
most common ﬁndings on TTE.
INFLUENCE OF AGE ON DIAGNOSTIC YIELD OF TTEs. The
age distribution for TTEs based on their primary
indication is shown in Figure 1. The most common
indication for TTE in children <10 years of age was
a murmur (innocent or pathologic), whereas chest
pain was the most common indication for those $10
years of age. Children with abnormal ﬁndings were
much younger than those with normal ﬁndings (me-
dian age: 1 vs. 10 years, respectively; p < 0.001). The
median age of patients who had TTEs performed for
indications rated R was 6 years compared to 10 years
TABLE 1 Diagnostic Yield of the 3 Most Frequently Used AUC Indications for Each Table Provided in the AUC Document
AUC Indication Number and Description Rating n
Number of TTE Findings (%)
Normal Incidental Abnormal
Palpitations
13. PVCs after the neonatal period M 29 28 (97) 0 (0) 1 (3)
2. Palpitations with no other symptoms or signs of cardiovascular disease, a benign
family history, and a normal ECG
R 23 22 (96) 1 (4) 0 (0)
3. Palpitations with abnormal ECG M 19 18 (95) 1 (5) 0 (0)
Syncope
25. Exertional syncope A 51 51 (100) 0 (0) 0 (0)
24. Unexplained pre-syncope M 38 38 (100) 0 (0) 0 (0)
19. Syncope with abnormal ECG A 33 32 (97) 1 (3) 0 (0)
Chest pain
30. Exertional chest pain A 355 351 (99) 2 (1) 2 (1)
29. Chest pain with other symptoms or signs of cardiovascular disease, a benign
family history, and a normal ECG
M 41 35 (85) 1 (2) 5 (12)
33. Non-exertional chest pain with abnormal ECG A 34 33 (97) 1 (3) 0 (0)
Murmur
41. Pathologic murmur A 446 194 (44) 74 (17) 178 (40)
39. Presumptively innocent murmur R 172 158 (92) 9 (5) 5 (3)
40. Presumptively innocent murmur with signs, symptoms or ﬁndings of
cardiovascular disease
A 160 132 (83) 15 (9) 13 (8)
Other Signs and Symptoms
42. Symptoms and/or signs suggestive of congestive heart failure A 13 11 (85) 0 (0) 2 (15)
43. Chest wall deformities and scoliosis pre-operatively M 10 9 (90) 0 (0) 1 (10)
44. Fatigue with no other signs and symptoms of cardiovascular disease, a normal
ECG, and a benign family history
R 9 9 (100) 0 (0) 0 (0)
Previous test results
52. Abnormal ECG results without symptoms A 279 255 (91) 8 (3) 16 (6)
49. Known channelopathy M 20 19 (95) 1 (5) 0 (0)
57. Chromosomal abnormality known to be associated with cardiovascular disease A 18 15 (83) 0 (0) 3 (17)
Systemic disorders
74. Systemic hypertension A 151 146 (97) 2 (1) 3 (2)
66. Suspected connective tissue disorder A 57 55 (95) 0 (0) 2 (4)
67. Clinically suspected syndrome or extracardiac congenital anomaly known to be
associated with congenital heart disease
A 48 41 (85) 0 (0) 7 (15)
Family history
100. Congenital left-sided heart lesion, including but not limited to mitral stenosis,
left ventricular outﬂow tract obstruction, bicuspid aortic valve, aortic coarctation,
and/or hypoplastic left heart syndrome
M 71 70 (99) 0 (0) 1 (3)
92. Hypertrophic cardiomyopathy A 41 38 (93) 2 (5) 1 (2)
94. Other cardiomyopathies A 24 22 (92) 1 (4) 1 (4)
Outpatient neonates
106. Suspected cardiovascular abnormality on fetal echocardiogram A 12 10 (83) 1 (8) 1 (8)
109. Maternal diabetes with no prior fetal echocardiogram M 2 1 (50) 0 (0) 1 (50)
107. Isolated echogenic focus on fetal ultrasound R 1 1 (100) 0 (0) 0 (0)
Percentages provided in the table have been rounded to the nearest whole number.
A ¼ appropriate; AUC ¼ appropriate use criteria; ECG ¼ electrocardiogram; M ¼ may be appropriate; PVCs ¼ premature ventricular contractions; R ¼ rarely appropriate;
TTE ¼ transthoracic echocardiogram.
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1136for those in whom it was done for indications rated A
or M (p ¼ 0.003). The likelihood of detecting an
abnormal ﬁnding was highest when TTE was per-
formed in those <1 year of age versus in those
>10 years of age (OR: 6.4; 95% CI: 4.7 to 8.7). After
we adjusted for indication and site, younger age
remained a signiﬁcant predictor of an abnormal
ﬁnding (OR [per 1-year decrease]: 1.04; 95% CI: 1.01 to
1.07; p ¼ 0.0004).GAPS IN THE CURRENT AUC DOCUMENT. Of 2,655
TTEs, 144 (5%) were unclassiﬁable. Table 3 shows a
summary of the unclassiﬁable scenarios. Family
history in a member other than a ﬁrst-degree rela-
tive and click on auscultation were the 2 most
common unclassiﬁable reasons for echo. Twenty-
four of the 113 indications (21%) were not used
(Table 4) for 1 of the following reasons: overlap with
other indications (7); rare condition in outpatient
TABLE 2 Most Common Abnormal Findings for Each Appropriateness Category, Severity of Abnormal Findings, and Percentage
of Abnormal Findings Related to the Indication
Rating (n)
3 Most Common
Abnormal Findings (n)
No. of Patients With Severity of
Abnormal Findings Shown (%)
No. of Patients With Abnormal
Findings Related to Indication (%)Minor Moderate Severe
Appropriate (245) VSD (79)
PS (46)
ASD (42)
171 (70) 69 (28) 5 (2) 226 (92)
May be appropriate (14) Mitral valve prolapse (6)
ASD (3)
Vascular ring (1)
14 (100) 0 (0) 0 (0) 7 (50)
Rarely appropriate (7) Coronary arteries (2)
Bicuspid aortic valve (1)
Pulmonary venous anomalies (1)
4 (57) 3 (43) 0 (0) 1 (14)
Unclassiﬁable (8) Mitral valve prolapse (2)
Bicuspid aortic valve (2)
ASD (1)
8 (100) 0 (0) 0 (0) 3 (38)
ASD ¼ atrial septal defect; PS ¼ pulmonary stenosis; VSD ¼ ventricular septal defect.
FIGURE 1 Age Distribution of Patients at the Time of TTE Based on Primary Indication
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The most common indication for transthoracic echocardiography (TTE) in children <10
years of age was a murmur (innocent or pathologic murmur), whereas in those $10 years
of age, the most common indication was chest pain. CV ¼ cardiovascular; ECG ¼ elec-
trocardiogram; FH ¼ family history.
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1137setting (7); overall rare condition (6); and indication
rated R for which TTE was not ordered on any
study patient (4).
DISCUSSION
With the release of the ﬁrst pediatric AUC, the ﬁeld of
pediatrics has entered territory that has been familiar
to the world of adult cardiology for the past decade.
This is the ﬁrst pediatric AUC implementation study
that has evaluated the appropriateness of TTEs per-
formed in a large number of patients seen in pediatric
cardiology clinics in multiple centers. We found that
most TTEs ordered in pediatric cardiology clinics
were for indications rated A (Central Illustration). AUC
ratings successfully stratiﬁed the indications based
on the yield of abnormal ﬁndings and identiﬁed
the common indications rated R. The likelihood of
detecting an abnormal TTE ﬁnding was the greatest
when TTE was done in infants and the indication
was rated A or M. This study also identiﬁed a small
number of unclassiﬁable indications. One of the
unique features of this study was that it was done
prior to the release of the AUC document; therefore
the physicians ordering the TTEs were unaware of the
AUC ratings. This approach provided us with baseline
information regarding the appropriateness of TTEs in
pediatric cardiology practice. Furthermore, it identi-
ﬁed the gaps in the current AUC document that
will be important during future revisions to this
document.
RATING AND FINDINGS OF TTEs. Most TTE’s per-
formed for a wide array of clinical indications were
rated A, and the rate of studies with indications rated
R was only 12%. Although 85% of the ﬁndings on TTE
were normal, most of the abnormal ﬁndings were
seen in indications rated A, and the ﬁndings noted inR were either minor or not related to the indication
itself. This suggests that the current AUC document
can reasonably stratify clinical indications based on
their yield of abnormal ﬁndings. This study identiﬁed
some commonly used indications rated R, such as
presumptively innocent murmurs, information that
can be used to lay the framework for educational in-
terventions to reduce the rate of TTEs ordered for
these indications. In addition, the presence of 1 or
more secondary ﬁndings did not affect the yield of
abnormal ﬁndings.
In contrast, implementation studies using the
initial adult AUC document for echocardiography
TABLE 3 Common Unclassiﬁable Reasons for Ordering Transthoracic Echocardiograms
Reason for Ordering TTE Number Ordered
Family history in a member other than ﬁrst-degree relative 32
Click 25
Hemangioma 9
Syncope at <5 years of age 8
Sinus tachycardia or suspected inappropriate sinus tachycardia 8
Abnormal heart sound other than click (split S1, S3, or unspeciﬁed gallop) 6
Apnea or apparent life-threatening event in an infant 4
Persistent cough, choking, or reﬂux (rule out vascular ring) 4
Anorexia nervosa 4
Unexplained syncope 3
Palpitations with exercise and a normal ECG and benign family history 3
Pectus or scoliosis (not pre-operative) 3
Migraine 3
Clearance of stimulant medications 2
Postural orthostatic tachycardia syndrome 2
Obstructive sleep apnea with no obesity 2
Other 26
Total 144
Abbreviations as in Table 1.
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ranging from 56% to 95% for the studies rated A (10–
14). A recent meta-analysis reporting temporal
changes in appropriateness of cardiac imaging
showed that there was a temporal improvement in
appropriateness of TTE (15), suggesting that as AUC
are more widely accepted in clinical practice pro-
viders may be more conscious of their own ordering
patterns.
INFLUENCE OF AGE ON DIAGNOSTIC YIELD OF TTE. Our
study showed that there was a signiﬁcant variation in
the indications for a TTE in different age groups. Also,
there was a much higher yield of abnormal ﬁndings in
studies done in infants compared to older children.
These ﬁndings are not surprising because a murmur
was the most common indication in younger patients,
and the highest yield of abnormal ﬁndings was in those
with murmurs. Similarly, chest pain was the most
common indication in older children and had a very
low yield of abnormal ﬁndings. Although these ﬁnd-
ings may not be new to experienced physicians, their
validation through the AUC document is of interest.
GAPS IN THE CURRENT AUC DOCUMENT. The current
AUC document captured 95% of the clinical scenarios
for TTEs ordered in pediatric cardiology clinics. The
yield of abnormal ﬁndings in the unclassiﬁable
studies was quite low in our study, and all ﬁndings
were minor. Two noteworthy scenarios that formed
a large proportion of unclassiﬁable studies were a
family history in a member other than a ﬁrst-degree
relative, such as in cousins or grandparents, and theauscultatory ﬁnding of a click. It is important to note
that the term “family history” in the current AUC
document is applicable only to ﬁrst-degree relatives.
Finding of an isolated click or other well-known
auscultatory abnormalities such as a gallop or rub
are clinically important indications that should be
included in future revisions. Furthermore, the in-
dications for syncope could probably be reﬁned by
including children younger than 5 years of age,
apnea, or apparent life-threatening events in infants,
postural orthostatic tachycardia syndrome, dizziness,
and unexplained syncope. Some additional indi-
cations that warrant attention are sinus tachycardia
and hemangiomas prior to initiation of propranolol
therapy. We realize that, despite our large sample
size, there are some other situations in which TTE is
used in clinical practice that may have escaped cap-
ture during our 6-month study period. One example
involves TTE referral for sports clearance, either by a
primary physician or upon parental request. It is also
important to recognize that at times there are situa-
tions in the pediatric cardiology clinic when patients,
parents, or referring physicians have an expectation
that TTE will be performed, despite the cardiologist’s
preference to not do it. These issues are not
addressed by the current AUC document.
It is important to note that our study identiﬁed a
relatively small gap compared to some of the studies
using the initial adult AUC document, which reported
as much as one-third of their studies as unclassiﬁable
(11). It is understandable that an AUC document can
by no means include every single possible case
scenario one could encounter in clinical practice.
Our study also identiﬁed 24 unused indications
and the possible reasons for lack of their use. During
future revisions of the document due consideration
could be given to avoid the overlap and consolidate
some of the rare conditions in outpatient settings.
FUTURE DIRECTIONS. This study has laid the foun-
dation for future efforts designed to improve the
appropriateness of TTEs ordered in outpatient pedi-
atric setting. Based on the information provided
by this study, educational interventions could be
targeted to reduce the use of TTE for common
indications rated R. Such interventions for adult
providers have included webinars, lectures, pocket
cards, and personal feedback via e-mails. Studies
have shown variable results in terms of achieving this
goal with some showing a high rate of success and
others showing none (8,9,16). Although our study
extensively evaluated the diagnostic yield of various
indications, the next step could be evaluation of the
clinical impact of the AUC in terms of any change in
patient care and its outcomes. A study in adults
TABLE 4 Indications in the AUC Document That Were Not Used in the Current Study
AUC Indication
Indication Number
in AUC Document Rating
Palpitations and arrhythmias
1 Palpitations with a family history of channelopathy 4 R
2 Palpitations in a patient with known channelopathy 5 M
3 Palpitations in a patient with known cardiomyopathy 8 A
4 PACs in the prenatal or neonatal period 9 R
5 Sinus arrhythmia 16 R
Syncope
6 Syncope or pre-syncope with a known noncardiovascular cause 27 R
Chest pain
7 Chest pain with family history of premature coronary
artery disease
35 M
8 Chest pain with recent illicit drug use 38 M
Previous test results
9 Genotype positive for cardiomyopathy 50 A
10 Desaturation based on pulse oximetry 53 A
11 Elevated anti-streptolysin O titers without suspicion for
rheumatic fever
56 R
12 Positive blood cultures suggestive of infective endocarditis 59 A
13 Abnormal cardiac enzyme test results 60 A
Systemic disorders
14 Cancer without chemotherapy 62 M
15 Human immunodeﬁciency virus infection 68 A
16 Suspected or conﬁrmed Takayasu arteritis 70 A
17 Diabetes mellitus 79 R
18 Abnormalities of visceral or cardiac situs 88 A
Family history of cardiovascular disease in patients without signs
or symptoms and without conﬁrmed cardiac diagnosis
19 Channelopathy 91 R
20 Heritable pulmonary arterial hypertension 103 A
21 Pulmonary arterial hypertension other than idiopathic
and heritable
104 R
22 Consanguinity 105 R
Outpatient neonates without post-natal cardiology evaluation
23 Maternal infection during pregnancy or delivery with potential
fetal/ neonatal cardiac sequelae
108 A
24 Maternal phenylketonuria 111 A
PAC ¼ premature atrial contraction; other abbreviations as in Table 1.
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were rated A, fewer than 1 in 3 resulted in an active
change in care (17). Despite the results of this study, it
is important to emphasize that when dealing with the
pediatric population, there may be signiﬁcant value
in having negative study results (i.e., normal exami-
nation ﬁndings) in several of the indications rated A.
For example, the yield of TTE for chest pain with
exertion, an indication rated A, was quite low for any
abnormal ﬁndings, and results for most studies were
normal. However, the value of such negative results
lies in reassurance and lifting of any restrictions on
sports activities that may have been placed on these
children prior to their visit to the cardiologist.
STUDY LIMITATIONS. Determination of indication
for TTE may not have been uniform among centers.
In addition, there may be an element of bias, because
site investigators were not blinded to the results of
TTE, even though the results of TTE were reviewed
after assigning the AUC indication. Also, the clini-
cians were made aware of data collection for the
study, and this could have inﬂuenced their decision
to order TTEs. Although the AUC document applies
to a TTE ordered by any provider, our study included
only patients that were evaluated by a pediatric
cardiologist because the orders received for TTEs by
other providers lacked details that were needed to
assign an AUC indication. Even though the bulk of
outpatient TTE’s in the real world are ordered by
pediatric cardiologists, the ﬁndings of this study may
not be generalizable as the distribution of appropri-
ateness rating may vary when the TTE is ordered by
primary care providers versus a specialist. We would
also like to acknowledge that this investigation was
not performed by an independent team as some of
the authors on this study were involved with the
development of the AUC document. In addition,
this study was supported by the American College of
Cardiology Appropriate Use Criteria Task Force.
CONCLUSIONS
The clinical application of the ﬁrst pediatric AUC was
feasible in this large multicenter study. Most TTEs
ordered by pediatric cardiologists for initial outpa-
tient evaluation were appropriate, and the majority of
the abnormal ﬁndings noted in this study were for
indications rated A or M. The pediatric AUC document
was able to successfully classify most studies. Future
reﬁnement of the AUC document should consider the
relatively small but important gaps identiﬁed through
this effort.
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PERSPECTIVES
COMPETENCY IN SYSTEM-BASED PRACTICE:
Baseline data for the use of transthoracic echocardiog-
raphy in pediatric patients before the release of evidence-
based AUC could be used by individual providers and
hospitals as benchmarks against which to compare uses
of this resource as ambulatory practice evolves.
TRANSLATIONAL OUTLOOK: Educational and quality
improvement programs should address the impact of AUC
not only on use of the targeted resource but on unin-
tended use of alternative diagnostic technologies, cost,
and ultimately on clinical outcomes.
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